KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2026)

Edwards Lifesciences has reported Gains from Investment Securities over the past 17 years, most recently at $7.4 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 87.18% year-over-year to $7.4 million; the TTM value through Dec 2025 reached -$13.4 million, down 123.43%, while the annual FY2025 figure was $7.4 million, 86.55% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $7.4 million at Edwards Lifesciences, up from -$12.5 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $96.6 million in Q4 2021 and troughed at -$102.6 million in Q2 2021.
  • A 5-year average of $1.1 million and a median of -$500000.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: surged 2510.81% in 2021 and later tumbled 1236.36% in 2022.
  • Year by year, Gains from Investment Securities stood at $96.6 million in 2021, then crashed by 70.5% to $28.5 million in 2022, then plummeted by 37.89% to $17.7 million in 2023, then soared by 225.99% to $57.7 million in 2024, then tumbled by 87.18% to $7.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for EW at $7.4 million in Q4 2025, -$12.5 million in Q3 2025, and -$8.2 million in Q2 2025.